Gain Therapeutics, Inc.GANXNASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank100
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
0.00%
↑ 100% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthStrong
Average
-12280.92%
Historical baseline
PeriodValueYoY Change
20240.00%+100.0%
2023-40176.79%-200.0%
2022-13390.10%-29.7%
2021-10320.49%+14.1%
2020-12014.32%-136.6%
2019-5078.66%-1.9%
2018-4986.06%-